IDEAS home Printed from https://ideas.repec.org/p/bsl/wpaper/2024-02.html
   My bibliography  Save this paper

On the Importance of Swiss Patient Data for Pharmaceutical R&D in Switzerland

Author

Listed:
  • Weder, Rolf
  • Bentele, Riccardo

Abstract

Real-world data (RWD) are an increasingly important input into the pharmaceutical R&D process as shown by countries like the USA or Finland. As the availability of and access to Swiss RWD is rather limited, the question arises whether this creates a burden for pharmaceutical R&D in Switzerland. We build on the economics of data and ideas as well as the home-market effect to analyze the importance of local RWD in the three stages of pharmaceutical R&D (pre-clinical, clinical, and post-approval re-search) as well as in the field of personalized medicine. We find qualitative support for a home-market effect and conclude that there is an urgent need to improve the current RWD situation in Switzerland, from the perspective of both Swiss patients and pharmaceutical R&D in Switzerland.

Suggested Citation

  • Weder, Rolf & Bentele, Riccardo, 2024. "On the Importance of Swiss Patient Data for Pharmaceutical R&D in Switzerland," Working papers 2024/02, Faculty of Business and Economics - University of Basel.
    • Handle: RePEc:bsl:wpaper:2024/02
    as

    Download full text from publisher

    File URL: https://edoc.unibas.ch/96350/1/WP_Bentele_Weder_Uni_Basel_Swiss_Patient_Data_and_Swiss_RD_2024.pdf
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    Patient Data; Real-World Data; Pharmaceutical R&D; Data and Innovation; Home-Market Effects; International Trade; Location of R&D;
    All these keywords.

    JEL classification:

    • F1 - International Economics - - Trade
    • O3 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights
    • L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bsl:wpaper:2024/02. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: WWZ (email available below). General contact details of provider: https://edirc.repec.org/data/wwzbsch.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.